...
首页> 外文期刊>RSC Advances >General and efficient synthesis of benzoxazol-2(3H)-ones: evolution of their anti-cancer and anti-mycobacterial activities
【24h】

General and efficient synthesis of benzoxazol-2(3H)-ones: evolution of their anti-cancer and anti-mycobacterial activities

机译:苯并恶唑-2(3H)-one的一般有效合成:其抗癌和抗分枝杆菌活性的演变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A novel class of benzo[d]oxazol-2(3H)-one derivatives has been synthesized and their in vitro cytotoxicity against human pancreatic adenocarcinoma and human non-small cell lung carcinoma cancer cell lines was evaluated. Many of these compounds were found to display excellent to moderate activity. Among them, 6b, 6l, 6n and 6x were identified as lead molecules. In particular, 6l and 6n were found to be potent against the pancreatic adenocarcinoma cell line whereas the 6x was found to be effective against the human non-small cell lung carcinoma cell line. Conversely, the compounds 6l-x were found to be ineffective against Mycobacterium tuberculosis. Of the various molecules, 6h showed promising anti-mycobacterial activity, with an IC50 value equal to that of ciprofloxacin.
机译:合成了一类新型的苯并[d]恶唑-2(3H)-一衍生物,并评估了它们对人胰腺腺癌和人非小细胞肺癌癌细胞系的体外细胞毒性。发现许多这些化合物显示出优异的至中等活性。其中,6b,6l,6n和6x被鉴定为铅分子。特别地,发现6l和6n对胰腺腺癌细胞系有效,而发现6x和6n对人非小细胞肺癌细胞系有效。相反,发现化合物61-x对结核分枝杆菌无效。在各种分子中,6h表现出有希望的抗分枝杆菌活性,IC50值等于环丙沙星。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号